Primary Progressive MS: Does Gender Matter?
…
Promising Phase 1 Trial Results of Stem Cell Therapy in Progressive MS Patients Being Presented at AAN Meeting
…
Stuart Schlossman
Biotin (Cerenday) for primary and secondary progressive multiple sclerosis – first line NIHR HSRIC
Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this…
Stuart Schlossman
MS SMART -Multiple Sclerosis – Secondary Progressive Multi-Arm Randomisation Trial
Update 1st April 2015 MS-SMART has started and recruitment into the trial will continue through 2015. Two centres are currently…
Stuart Schlossman
B Vitamin Promising in Progressive Multiple Sclerosis
Pauline Anderson Washington, DC — A regimen of high doses of biotin, a water-soluble B vitamin, appears to be effective…
Stuart Schlossman
NEWS FLASH for people with PPMS— FDA GRANTS BREAKTHROUGH THERAPY DESIGNATION FOR GENENTECH’S INVESTIGATIONAL MEDICINE OCRELIZUMAB IN PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS
· Ocrelizumab is the first investigational medicine to receive Breakthrough Therapy Designation in multiple sclerosis (MS) · Twelfth Breakthrough Therapy…
Stuart Schlossman
Primary Progressive Multiple Sclerosis (PPMS) Therapeutic Pipeline Review, H2 2015
Primary Progressive Multiple Sclerosis (PPMS) – Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Primary Progressive Multiple Sclerosis (PPMS) –…
Stuart Schlossman
Ocrelizumab Proven Effective In Multiple Sclerosis Treatment for Primary Progressive MS (PPMS)
Successful clinical trial results by Bay Area researchers was released Thursday on a new drug that shows promise to become…
Stuart Schlossman
BREAKING MS NEWS: Genentech’s Ocrelizumab First Investigational Medicine to Show Efficacy in People with Primary Progressive Multiple Sclerosis in Large Phase III Study
Phase III study meets primary endpoint in debilitating form of multiple sclerosis with no approved treatments Ocrelizumab is the first…
Stuart Schlossman
Stem Cells Used to Treat Secondary Progressive Patients in Clinical Trial
What may work better than existing drugs to treat severe multiple sclerosis? Stem cells. A phase 2 clinical study…
Stuart Schlossman
